These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18094947)

  • 41. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Internalization of constitutive desmogleins with the subsequent induction of desmoglein 2 in pemphigus lesions.
    Iwatsuki K; Han GW; Fukuti R; Ohtsuka M; Kikuchi S; Akiba H; Kaneko F
    Br J Dermatol; 1999 Jan; 140(1):35-43. PubMed ID: 10215765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.
    Loiseau P; Lecleach L; Prost C; Lepage V; Busson M; Bastuji-Garin S; Roujeau JC; Charron D
    J Autoimmun; 2000 Aug; 15(1):67-73. PubMed ID: 10936030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    Bhatia SM; Streilein RD; Hall RP
    PLoS One; 2020; 15(6):e0233957. PubMed ID: 32555697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
    Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
    J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N; Gombos F; Lanza A
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Src and Cortactin in Pemphigus Skin Blistering.
    Kugelmann D; Rötzer V; Walter E; Egu DT; Fuchs MT; Vielmuth F; Vargas-Robles H; Schnoor M; Hertl M; Eming R; Rottner K; Schmidt A; Spindler V; Waschke J
    Front Immunol; 2019; 10():626. PubMed ID: 31024527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The desmosome and hemidesmosome in cutaneous autoimmunity.
    Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris: comparison of 14 cases of pemphigus vulgaris and 10 cases of pemphigus foliaceus studied by western immunoblot and immunoelectron microscopy.
    Bédane C; Prost C; Thomine E; Intrator L; Joly P; Caux F; Blecker M; Bernard P; Leboutet MJ; Tron F; Lauret P; Bonnetblanc JM; Dubertret L
    Arch Dermatol Res; 1996 Jun; 288(7):343-52. PubMed ID: 8818180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes.
    Aoyama Y; Nagai M; Kitajima Y
    Br J Dermatol; 2010 May; 162(5):1049-55. PubMed ID: 20222919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune response in pemphigus and beyond: progresses and emerging concepts.
    Di Zenzo G; Amber KT; Sayar BS; Müller EJ; Borradori L
    Semin Immunopathol; 2016 Jan; 38(1):57-74. PubMed ID: 26597100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Internalization of non-clustered desmoglein 1 without depletion of desmoglein 1 from adhesion complexes in an experimental model of the autoimmune disease pemphigus foliaceus.
    Lanza A; De Rosa A; Femiano F; Annese P; Ruocco E; Gombos F; Lanza M; Cirillo N
    Int J Immunopathol Pharmacol; 2007; 20(2):355-61. PubMed ID: 17624248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Desmosomal cadherins and signaling: lessons from autoimmune disease.
    Spindler V; Waschke J
    Cell Commun Adhes; 2014 Feb; 21(1):77-84. PubMed ID: 24460203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pemphigus foliaceus.
    Dasher D; Rubenstein D; Diaz LA
    Curr Dir Autoimmun; 2008; 10():182-94. PubMed ID: 18460886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.
    Yokouchi M; Saleh MA; Kuroda K; Hachiya T; Stanley JR; Amagai M; Ishii K
    J Invest Dermatol; 2009 Sep; 129(9):2156-66. PubMed ID: 19340014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
    Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.